The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Angiogenesis in Endocrine Tumors
Abstract
Angiogenesis is the process of new blood vessel development from preexisting vasculature. Although vascular endothelium is usually quiescent in the adult, active angiogenesis has been shown to be an important process for new vessel formation, tumor growth, progression, and spread. The angiogenic phenotype depends on the balance of proangiogenic growth factors such as vascular endothelial growth factor (VEGF) and inhibitors, as well as interactions with the extracellular matrix, allowing for endothelial migration. Endocrine glands are typically vascular organs, and their blood supply is essential for normal function and tight control of hormone feedback loops. In addition to metabolic factors such as hypoxia, the process of angiogenesis is also regulated by hormonal changes such as increased estrogen, IGF-I, and TSH levels. By measuring microvascular density, differences in angiogenesis have been related to differences in tumor behavior, and similar techniques have been applied to both benign and malignant endocrine tumors with the aim of identification of tumors that subsequently behave in an aggressive fashion. In contrast to other tumor types, pituitary tumors are less vascular than normal pituitary tissue, although the mechanism for this observation is not known. A relationship between angiogenesis and tumor size, tumor invasiveness, and aggressiveness has been shown in some pituitary tumor types, but not in others. There are few reports on the role of microvascular density or angiogenic factors in adrenal tumors. The mechanism of the vascular tumors, which include adrenomedullary tumors, found in patients with Von Hippel Lindau disease has been well characterized, and clinical trials of antiangiogenic therapy are currently being performed in patients with Von Hippel Lindau disease. Thyroid tumors are more vascular than normal thyroid tissue, and there is a clear correlation between increased VEGF expression and more aggressive thyroid tumor behavior and metastasis. Although parathyroid tissue induces angiogenesis when autotransplanted and PTH regulates both VEGF and MMP expression, there are few studies of angiogenesis and angiogenic factors in parathyroid tumors. An understanding of the balance of angiogenesis in these vascular tumors and mechanisms of vascular control may assist in therapeutic decisions and allow appropriately targeted treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–296 of 296
Editorial: Is Tissue Mass Regulated by Vascular Endothelial Cells? Prostate as the First Evidence
Folkman, J. (1998) · Endocrinology · doi:10.1210/endo.139.2.5858 · Cited by 106
Nakajima, M., Welch, D. R., Wynn, D. M., Tsuruo, T., & Nicolson, G. L. (1993) · PubMed · Cited by 105
Viglietto, G., Romano, A., Manzo, G., Chiappetta, G., Paoletti, I., Califano, D., Galati, M. G., Mauriello, V., Bruni, P., Lago, C. T., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201456 · Cited by 105
Talbot, B., & Brown, P. D. N. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00398-x · Cited by 105
Inhibition of Angiogenesis by Somatostatin and Somatostatin-like Compounds Is Structurally Dependent
Barrie, R. J., Woltering, E. A., Hajarizadeh, H., Mueller, C., Ure, T., & Fletcher, W. S. (1993) · Journal of Surgical Research · doi:10.1006/jsre.1993.1167 · Cited by 104
Rajah, R., Nunn, S. E., Herrick, D., GRUNSTEIN, M. M., & Cohen, P. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.271.6.l1014 · Cited by 103
Martin, D. C., Fowlkes, J. L., Babic, B., & Khokha, R. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.4.881 · Cited by 101
Antiangiogenic effects of somatostatin analogues
de la Torre, N. G., Wass, J. A. H., & Turner, H. E. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01619.x · Cited by 101
Self-citationMira, E., Mañes, S., Lacalle, R. A., Márquez, G., & Martínez‐A, C. (1999) · Endocrinology · doi:10.1210/endo.140.4.6623 · Cited by 100
Lee, O.-H., Bae, S. K., Bae, M., Lee, Y. M., Moon, E., J, H., Kwon, Y., & Kim, K. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0931 · Cited by 99
Gloddek, J., Pagotto, U., Páez-Pereda, M., ARZT, E. S., Stalla, G. K., & Renner, U. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600483 · Cited by 98
Ponton, A., Coulombe, B., & Skup, D. (1991) · PubMed · Cited by 97
Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function
Jf, W., Milosveski, V., Schramek, C., Fong, G. H., Becks, G. P., & Hill, D. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1570005 · Cited by 96
Expression of vascular endothelial growth factor in human brain tumors
Nishikawa, R., Cheng, S., Nagashima, R., Huang, H., Cavenee, W. K., & Matsutani, M. (1998) · Acta Neuropathologica · doi:10.1007/s004010050919 · Cited by 95
Blood Capillary Enlargement during the Development of Thyroid Hyperplasia in the Rat
Wollman, S. H., Herveg, J. P., Zeligs, J. D., & Ericson, L. E. (1978) · Endocrinology · doi:10.1210/endo-103-6-2306 · Cited by 92
D’Angelo, G., Martini, J., Iiri, T., Fantl, W. J., MARTIAL, J. A., & Weiner, R. I. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.5.0280 · Cited by 88
H�fler, H., Walter, G. F., & Denk, H. (1984) · Acta Neuropathologica · doi:10.1007/bf00689825 · Cited by 86
Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties.
Dhanabal, M., LaRochelle, W. J., Jeffers, M., Herrmann, J. L., Rastelli, L., McDonald, W. F., Chillakuru, R. A., Yang, M., Boldog, F. L., Padigaru, M., et al. (2002) · PubMed · Cited by 86
Belfiore, A., Gangemi, P., Costantino, A., Russo, G. M., Santonocito, G. M., Ippolito, O., Renzo, M. F. D., Comoglio, P. M., Fiumara, A., & Vigneri, R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4104 · Cited by 83
Lohrer, P., Gloddek, J., Hopfner, Ú., Losa, M., Uhl, E., Pagotto, U., Stalla, G. K., & Renner, U. (2001) · Neuroendocrinology · doi:10.1159/000054675 · Cited by 81
Ultrastructural changes in the capillary bed of human pituitary tumors.
Schechter, J. (1972) · PubMed · Cited by 79
The Primary Angiographic Findings in Pituitary Adenomas
Powell, D. F., Baker, H. L., & Laws, E. R. (1974) · Radiology · doi:10.1148/110.3.589 · Cited by 79
Vascular endothelial growth factor–C gene expression in papillary and follicular thyroid carcinomas
Fellmer, P., Sato, K., Tanaka, R. J., Okamoto, T., Kato, Y., Kobayashi, M., Shibuya, M., & Obara, T. (1999) · Surgery · doi:10.1067/msy.2099.101432 · Cited by 78
Shifren, J. L., Mesiano, S. A., Taylor, R. N., Ferrara, N., & Jaffe, R. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4730 · Cited by 78
Reduced Retinal Vascularization in Children with Growth Hormone Deficiency
Hellström, A., Svensson, E., Carlsson, B., Niklasson, A., & Albertsson-Wikland, K. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5484 · Cited by 77
Ogawa, T., Takayama, K., Takakura, N., Kitano, S., & Ueno, H. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700478 · Cited by 76
Harris, A. L. (2000) · The Oncologist · doi:10.1634/theoncologist.5-suppl_1-32 · Cited by 76
Self-citationChaudhry, A., Öberg, K., Gobl, A., Heldin, C., & Funa, K. (1994) · PubMed · Cited by 76
Kuroda, M., Oka, T., Oka, Y., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593426 · Cited by 75
Sequential MR enhancement pattern in normal pituitary gland and in pituitary adenoma.
Yuh, W. T. C., Fisher, D. J., Nguyen, H. D., Talı, E. T., Gao, F., Simonson, T. M., & Schlechte, J. (1994) · PubMed · Cited by 74
Lees, P. D., & Pickard, J. D. (1987) · Journal of neurosurgery · doi:10.3171/jns.1987.67.2.0192 · Cited by 74
Rooman, I., Schuit, F., & Bouwens, L. (1997) · PubMed · Cited by 74
Expression of the vascular endothelial growth factor gene is inhibited by p73
Salimath, B. P., Marmé, D., & Finkenzeller, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203672 · Cited by 73
Akita, S., Readhead, C. W., Ştefăneanu, L., Fine, J., Tampanaru-Sarmesiu, A., Kovács, K., & Melmed, S. K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119430 · Cited by 71
Self-citationExpression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms
Katoh, R., Miyagi, E., Kawaoi, A., Hemmi, A., Komiyama, A., Oyama, T., & Shibuya, M. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90241-1 · Cited by 70
Rymaszewski, Z., Cohen, R. M., & Chomczyński, P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.617 · Cited by 69
Basic Fibroblast Growth Factor: Production and Growth Stimulation in Cultured Adrenal Cortex Cells*
Schweigerer, L., Neufeld, G., Friedman, J. S., Abraham, J. A., Fiddes, J. C., & Gospodarowicz, D. (1987) · Endocrinology · doi:10.1210/endo-120-2-796 · Cited by 67
Trovato, M. C., Villari, D., Bartolone, L., et al. (1998) · Thyroid · doi:10.1089/thy.1998.8.125 · Cited by 67
Expression of Angiogenic Growth Factors in Paragangliomas
Jyung, R. W., LeClair, E. E., Bernat, R. A., Kang, T. S., Ung, F., McKenna, M. J., & Tuan, R. S. (2000) · The Laryngoscope · doi:10.1097/00005537-200001000-00029 · Cited by 67
Cleaved Prolactin: Evidence for Its Occurrence in Human Pituitary Gland and Plasma*
Sinha, Y. N., Gilligan, T., LEE, D. W., Hollingsworth, D. R., & Markoff, E. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-2-239 · Cited by 66
Esbrit, P., Alvarez-Arroyo, M. V., Miguel, F. D., Martin, O. I., Martinez, M. E., & Caramelo, C. A. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1161085 · Cited by 66
Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas
Kawamoto, H., UOZUMI, T., Kawamoto, K., Arita, K., Takafumi, Y. A. N. O., & HIROHATA, T. (1996) · Acta Neurochirurgica · doi:10.1007/bf01420300 · Cited by 65
Bermont, L., Lamielle, F., Fauconnet, S., Esumi, H., Weisz, A., & Adessi, G. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<117::aid-ijc21>3.0.co;2-x · Cited by 64
Fan, L., & Iseki, S. (1998) · Archivum histologicum japonicum · doi:10.1679/aohc.61.17 · Cited by 63
Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36.
Williamson, C., Pannett, A. A. J., Pang, J. T., Wooding, C., McCarthy, M. I., Sheppard, M. N., Monson, J., Clayton, R. N., & Thakker, R. V. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.8.617 · Cited by 63
Expression of fibroblast growth factors in thyroid cancer
Eggo, M. C., Hopkins, J., Franklyn, J. A., Johnson, G. D., Sanders, D. S. A., & Sheppard, M. C. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7533768 · Cited by 62
Thompson, S. D., Franklyn, J. A., Watkinson, J. C., Verhaeg, J. M., Sheppard, M. C., & Eggo, M. C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4723 · Cited by 62
Kawashima‐Ohya, Y., Satakeda, H., Kuruta, Y., Kawamoto, T., Yan, W., Akagawa, Y., Hayakawa, T., Noshiro, M., Okada, Y., Nakamura, S., et al. (1998) · Endocrinology · doi:10.1210/endo.139.4.5941 · Cited by 62
Bar, M., Friedman, E., Jakobovitz-Picard, O., Leibowitz, G., Lerer, I., Abeliovich, D., & Gross, D. J. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.3251150.x · Cited by 59
Corticotropin-Releasing Hormone Stimulates Angiogenesis and Epithelial Tumor Growth in the Skin
Arbiser, J. L., Karalis, K. P., Viswanathan, A. N., Koike, C., Anand‐Apte, B., Flynn, E. A., Zetter, B. R., & Majzoub, J. A. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00760.x · Cited by 57
Patel, P., Barrie, R. J., Hill, N. S., Landeck, S., Kurozawa, D., & Woltering, E. A. (1994) · PubMed · Cited by 57
Ochoa, A., Mitchner, N. A., Paynter, C., Morris, R. E., & Ben‐Jonathan, N. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650483 · Cited by 56
McClelland, P., Onyia, J. E., Miles, R. R., Tu, Y., Liang, J., Harvey, A. K., Chandrasekhar, S., Hock, J. M., & Bidwell, J. P. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980901)70:3<391::aid-jcb12>3.0.co;2-o · Cited by 55
Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.
Taraboletti, G., Micheletti, G., Rieppi, M., Poli, M., Turatto, M., Rossi, C., Borsotti, P., Roccabianca, P., Scanziani, E., Nicoletti, M. I., et al. (2002) · PubMed · Cited by 55
Gicquel, C., Bertherat, J. Y., Bouc, Y. L., & BERTAGNA, X. Y. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70112-2 · Cited by 54
Tahara, H., Smith, A. P., Gaz, R. D., & Arnold, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3663 · Cited by 54
Parathyroid Hormone-Related Peptide Is a Potent Tumor Angiogenic Factor
Akino, K., Ohtsuru, A., Kanda, K., Yasuda, A., Yamamoto, T., Akino, Y., Naito, S., Kurokawa, M., Iwahori, N., & Yamashita, S. (2000) · Endocrinology · doi:10.1210/endo.141.11.7875 · Cited by 54
Gould, J. C., Arámburo, C., Capdevielle, M. C., & Scanes, C. G. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00491-a · Cited by 53
Microadenomas of the Human Pituitary and Their Vascularization
Gorczyca, W. A., & Hardy, J. (1988) · Neurosurgery · doi:10.1227/00006123-198801000-00001 · Cited by 52
Salvén, P., Joensuu, H., Heikkilä, P., Matikainen, M.-T., Wasenius, V.-M., Alanko, A., & Alitalo, K. K. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.317 · Cited by 50
Torner, L., Mejía, S., López-Gómez, F. J., Quintanar, A., de la Escalera, G. M., & Clapp, C. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588295 · Cited by 49
Jabbour, H. N., Boddy, S. C., & Lincoln, G. A. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00158-5 · Cited by 49
Konno, H., Arai, T., Tanaka, T., Baba, M., Matsumoto, K., Kanai, T., Nakamura, S., Baba, S., Naito, Y., Sugimura, H., et al. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00651.x · Cited by 49
Sinha, Y. N., & Gilligan, T. (1984) · Endocrinology · doi:10.1210/endo-114-6-2046 · Cited by 49
Narimatsu, M., Nagayama, Y., Akino, K., Yasuda, M., Yamamoto, T., Yang, T., Ohtsuru, A., Namba, H., Yamashita, S., Ayabe, H., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3668 · Cited by 49
Schechter, J., Ahmad, N., & Weiner, R. I. (2008) · Neuroendocrinology · doi:10.1159/000125064 · Cited by 48
Sacco, M. G., Caniatti, M., Catò, E. M., Frattini, A., Chiesa, G., Ceruti, R., Adorni, F., Zecca, L., Scanziani, E., & Vezzoni, P. (2000) · PubMed · Cited by 46
Vascularity in human adrenal cortex.
Sasano, H., Ohashi, Y., Suzuki, T., & Nagura, H. (1998) · PubMed · Cited by 45
Banerjee, S. K., Campbell, D. R., Weston, A. P., & Banerjee, D. K. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006888020596 · Cited by 43
Damjanovski, S., Puzianowska‐Kuźnicka, M., Ishizuya‐Oka, A., & Shi, Y. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.3.503 · Cited by 43
Basic fibroblast growth factor: an autocrine mitogen of rat thyroid follicular cells?
Logan, A., Black, E. G., Gonzalez, A. M., Buscaglia, M., & Sheppard, M. C. (1992) · Endocrinology · doi:10.1210/endo.130.4.1312454 · Cited by 43
Los, M., Zeamari, S., Foekens, J. A., Gebbink, M. F. B. G., & Voest, E. E. (1999) · PubMed · Cited by 43
Estrogen‐induced tumors: Changes in the vasculature in two strains of rat
Schechter, J., Ahmad, N., Elias, K. A., et al. (1987) · American Journal of Anatomy · doi:10.1002/aja.1001790402 · Cited by 42
Shingū, K., FUJIMORI, M., Ito, K., et al. (1998) · Endocrine Journal · doi:10.1507/endocrj.45.35 · Cited by 41
Merkle, C. J., Schuler, L. A., Schaeffer, R. C., Gribbon, J. M., & Montgomery, D. W. (2000) · Endocrine · doi:10.1385/endo:13:1:37 · Cited by 40
Kakolyris, S., Giatromanolaki, A. N., Koukourakis, M. I., Leigh, I. M., Georgoulias, V., Kanavaros, P., Sivridis, E., Gatter, K. C., & Harris, A. L. (1999) · PubMed · Cited by 36
Self-citationc‐Met expression of thyroid tissue with special reference to papillary carcinoma
Oyama, T., Ichimura, E., Sano, T., et al. (1998) · Pathology International · doi:10.1111/j.1440-1827.1998.tb03835.x · Cited by 34
Luca, A. D., Arena, N., Sena, L. M., & Médico, E. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199909)180:3<365::aid-jcp7>3.0.co;2-b · Cited by 34
Basic fibroblast growth factor may mediate proliferation in the compensatory adrenal growth response
Basile, D. P., & Holzwarth, M. A. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.265.6.r1253 · Cited by 33
Pituitary, adrenal and thyroid incidentalomas
Turner, H. E., Moore, N. R., Byrne, J. V., & Wass, J. A. H. (1998) · Endocrine Related Cancer · doi:10.1677/erc.0.0050131 · Cited by 32
Self-citationGross, D. J., Reibstein, I., Weiss, L., et al. (1999) · PubMed · Cited by 30
Iruela‐Arispe, M. L., Vázquez, F., & Ortega, M.-A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09400.x · Cited by 30
Thyroid Angiogenesis: Endotheliotropic Chemoattractant Activity from Rat Thyroid Cells in Culture*
Goodman, A. L., & Rone, J. D. (1987) · Endocrinology · doi:10.1210/endo-121-6-2131 · Cited by 30
Stimulation of lactotrope differentiation in vitro by fibroblast growth factor
Porter, T. E., Wiles, C. D., & Frawley, L. S. (1994) · Endocrinology · doi:10.1210/endo.134.1.7506204 · Cited by 29
Shifren, J. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1342 · Cited by 29
Mukhopadhyay, D., Tsiokas, L., & Sukhatme, V. P. (1998) · Europe PMC (PubMed Central) · Cited by 27
Farnoud, M. R., Lissak, B., Kujas, M., Peillon, F., Racadot, J., & Li, J. Y. (1992) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01606873 · Cited by 27
Release of an Endothelial Cell Growth Factor from Cultured Porcine Thyroid Follicles
Greil, W., Rafferzeder, M., Bechtner, G., & Gärtner, R. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-5-858 · Cited by 27
Kebebew, E., Wong, M. G., SIPERSTEIN, A. E., Duh, Q., & Clark, O. H. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5913 · Cited by 25
Artini, P. G., Monti, M., Fasciani, A., Tartaglia, M. L., D’Ambrogio, G., & Genazzani, A. R. (1998) · Gynecological Endocrinology · doi:10.3109/09513599809015596 · Cited by 25
Cai, Y.-C., Barnard, G. F., Hiestand, L., Woda, B. A., Colby, J. M., & Banner, B. F. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199711000-00013 · Cited by 25
Oxygen homeostasis and cancer: insights from a rare disease
Maxwell, P. H. (2002) · Clinical Medicine · doi:10.7861/clinmedicine.2-4-356 · Cited by 23
Ali, S. H., O’Donnell, A. L., Mohamed, S. N., Mousa, S. A., & Dandona, P. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00065-9 · Cited by 22
Inhibition of malignant angiogenesis
Jekunen, A. P., & Kairemo, K. (1997) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(97)90014-1 · Cited by 18
Vermeulen, P., Dirix, L. Y., Libura, J., Vanhoolst, I. F., Marck, E. V., & van Oosterom, A. T. (1997) · Microvascular Research · doi:10.1006/mvre.1997.2019 · Cited by 16
Control of the adrenocortical cell cycle: interaction between FGF2 and ACTH
Armelin, H. A., & Lotfi, C. F. P. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000700007 · Cited by 9
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
Kulke, M. H., Lenz, H.-J., Meropol, N. J., Posey, J., Ryan, D. P., Picus, J., Bergsland, E., Stuart, K., Tye, L., Huang, X., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9020 · Cited by 623
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Kloos, R. T., Ringel, M. D., Knopp, M. V., Hall, N. C., King, M., Stevens, R., Liang, J., Wakely, P. E., Vasko, V. V., Saji, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2717 · Cited by 541
Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
Vaupel, P. (2008) · The Oncologist · doi:10.1634/theoncologist.13-s3-21 · Cited by 383
Metadata
- Authors
- Turner, H. E., Harris, A. L., Melmed, S., & Wass, J. A. H.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-10-01
- Volume
- 24
- Issue
- 5
- Pages
- 600-632
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2125153669
- Cited by
- 275
- References
- 296
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.